BioSpace News Archive

Business

Amarin Reports Second Quarter 2023 Financial Results

Amarin Corporation plc (NASDAQ:AMRN) today announced financial results for the quarter ended June 30, 2023 and provided an update on company operations.

August 2, 2023
·
15 min read
Pharm Country

Anavex Life Sciences to Present at the BTIG Virtual Biotechnology Conference 2023

Anavex Life Sciences Corp today announced that Christopher U. Missling, PhD, President and Chief Executive Officer of Anavex, will participate in a fireside chat at the BTIG Virtual Biotechnology Conference 2023, taking place on August 7-8, 2023.

August 2, 2023
·
3 min read
Biotech Bay

Apogee Therapeutics to Participate in Upcoming August Investor Conferences

Apogee Therapeutics, Inc. today announced that management will participate in the following upcoming investor conferences.

August 2, 2023
·
1 min read
Business

Repligen Reports Second Quarter 2023 Financial Results and Updates Full Year 2023 Financial Guidance

Repligen Corporation today reported financial results for its second quarter (Q2) and first half (H1) of 2023, covering the three- and six-month fiscal periods ended June 30, 2023.

August 2, 2023
·
21 min read
Genetown

First Patient Enrolled in LEOPARD, an Investigator-Initiated Trial, with OCS-01 Eye Drops for the Treatment of Cystoid Macular Edema

Oculis Holding AG announces that the first patient has been enrolled in the investigator-initiated LEOPARD trial evaluating the potential of OCS-01 eye drops, Oculis’ novel high concentration preservative-free topical OPTIREACH formulation of dexamethasone, for the treatment of cystoid macular edema.

August 2, 2023
·
6 min read
Business

Bionano to Report Second Quarter 2023 Financial Results and Host a Conference Call and Webcast on August 9, 2023

Bionano Genomics, Inc. announced that it will host a conference call and live webcast on Wednesday, August 9, 2023, at 4:30 p.m. Eastern Time to report financial results for the second quarter 2023 and to highlight recent corporate progress.

August 2, 2023
·
1 min read
Business

Jasper Therapeutics Strengthens Management Team with Key Appointments

Jasper Therapeutics, Inc. today announced the appointment of two seasoned pharma industry executives to its regulatory affairs, quality and clinical operations leadership teams.

August 2, 2023
·
6 min read
Business

Talis Biomedical Announces Andrew Lukowiak, Ph.D., as President and Chief Scientific Officer (CSO)

Talis Biomedical Corporation today announced that it has appointed Dr. Andrew A. Lukowiak as president and chief scientific officer, effective August 1, 2023.

August 2, 2023
·
5 min read
Biotech Beach

Regulus Therapeutics to Present at the Canaccord Genuity 43rd Annual Growth Conference

Regulus Therapeutics Inc today announced that CEO Jay Hagan will be presenting at the Canaccord Genuity 43rd Annual Growth Conference on Wednesday, August 9, 2023.

August 2, 2023
·
3 min read
Genetown

NeuroBo Pharmaceuticals Enters Into Term Sheet With MThera Pharma to Out-license NB-01

NeuroBo Pharmaceuticals, Inc. today announced that it has entered into a term sheet with MThera Pharma Co., Ltd. (MTHERA) which provides for the terms under which NeuroBo will out-license the worldwide rights, outside of Korea, for NB-01 for the treatment of painful diabetic neuropathy to MTHERA.

August 2, 2023
·
6 min read